SK Bioscience Co

SK Bioscience Co Dividend

Dividend of SK Bioscience Co (302440.KS) as of Nov 4, 2026.

Dividend

0.00KRW

Last updated:

How much dividend does SK Bioscience Co 2026 pay?

According to the latest status from November 2026, SK Bioscience Co paid a total of 0.00 KRW per share in dividends within the last 12 months. With the current SK Bioscience Co price of 33,250.00 KRW, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical SK Bioscience Co Dividends

Historical SK Bioscience Co Dividends
PaydateDividend

The SK Bioscience Co Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2021
0.00 KRW
Jan 1, 2022
0.00 KRW
Jan 1, 2023
0.00 KRW
Jan 1, 2024
0.00 KRW
Jan 1, 2025
0.00 KRW
Jan 1, 2026 (e)
0.00 KRW
Jan 1, 2027 (e)
0.00 KRW
Jan 1, 2028 (e)
0.00 KRW
The SK Bioscience Co Dividend history
YEARDividendYoY
est0.00KRW—
est0.00KRW—
est0.00KRW—
0.00KRW—
0.00KRW—
0.00KRW—
0.00KRW—
0.00KRW—
0.00KRW—
0.00KRW—
0.00KRW—

Is the SK Bioscience Co Dividend Safe?

SK Bioscience Co has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding SK Bioscience Co's Dividend Distributions

SK Bioscience Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining SK Bioscience Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

SK Bioscience Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in SK Bioscience Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

SK Bioscience Co Stock analysis

What does SK Bioscience Co do? SK Bioscience Co Ltd is a South Korean biotechnology company headquartered in Seongnam, Gyeonggi-Do. The company went public on March 18, 2021, with its stock listed on the Korean Stock Exchange under the ticker 302440.KS. It operates within the health care sector, specifically in the biotechnology industry. SK Bioscience employs 1,067 people and focuses on the development and distribution of bio and vaccine products. The company distributes its products both domestically and internationally. While specific product names are mentioned in unverified sources, the company is known to be involved in the production of vaccines and infusion solutions. It also engages in technology export business, though detailed information about its technology or export markets is not provided. The company's website is https://www.skbioscience.co.kr/, where further information about its operations and products may be available. SK Bioscience does not disclose specific details about its product lines beyond the general categories of vaccines and infusion solutions, and it does not provide information on acquisitions, founding year, or key personnel. The company's activities are centered around biotechnology and healthcare, with a focus on vaccine development and distribution. Its market presence spans both domestic and international markets, though specific regions or countries are not specified. The company's financial data, including revenue and market capitalization, is not included in the provided information. SK Bioscience is a publicly traded company with a focus on biotechnology and healthcare innovation. SK Bioscience Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SK Bioscience Co stock

SK Bioscience Co paid dividends every year for the past 0 years.

SK Bioscience Co is assigned to the 'Health' sector.

The dividends of SK Bioscience Co are distributed in KRW.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — SK Bioscience Co